Immediate Impact
3 from Science/Nature 56 standout
Citing Papers
JAK inhibition enhances checkpoint blockade immunotherapy in patients with Hodgkin lymphoma
2024 StandoutScience
Cell death
2024 Standout
Works of Inho Kim being referenced
Venetoclax or placebo in combination with bortezomib and dexamethasone in patients with relapsed or refractory multiple myeloma (BELLINI): a randomised, double-blind, multicentre, phase 3 trial
2020 Standout
Efficacy Of Ruxolitinib In Korean Myelofibrosis Patients and Cases Complicated TB Lymphadenitis During The Treatment
2013
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Inho Kim | 841 | 490 | 271 | 523 | 176 | 1.6k | |
| Hawk Kim | 867 | 434 | 337 | 340 | 110 | 1.4k | |
| Seonyang Park | 647 | 303 | 179 | 384 | 132 | 1.5k | |
| Atul Sharma | 460 | 536 | 250 | 446 | 175 | 1.6k | |
| Kazuteru Ohashi | 920 | 332 | 520 | 427 | 129 | 1.9k | |
| H. Kronenberg | 823 | 253 | 312 | 284 | 125 | 1.8k | |
| Sevgi Yetgin | 496 | 321 | 180 | 595 | 109 | 1.8k | |
| Takayuki Saitoh | 803 | 336 | 434 | 575 | 144 | 1.9k | |
| Hongsheng Zhou | 730 | 303 | 384 | 559 | 125 | 1.6k | |
| Hyun‐Sook Chi | 701 | 349 | 254 | 272 | 98 | 1.4k | |
| Noriko Doki | 862 | 307 | 213 | 383 | 174 | 1.5k |
All Works
Login with ORCID to disown or claim papers
Loading papers...